VeroScience
is a biotechnology company that is focused on the development of therapies and products to improve human health... Read moreVeroScience
is a biotechnology company that is focused on the development of therapies and products to improve human health... Read more
President
Anthony H. Cincotta
News
Jun 09, 2019
PR Newswire
Press Release: VeroScience : VeroScience Presents New Pipeline Data for Metabolic Disease Therapies at 2019 American Diabetes Association Meeting
Jun 12, 2016
BioSpace
VeroScience: VeroScience Continues To Explore Clinical Benefits Of Circadian Neuroendocrine Resetting Therapy With Six Papers Presented At 2016 American Diabetes Association Scientific Sessions June 10-14
Jun 12, 2016
BioSpace
VeroScience: VeroScience Is Pleased To Support Independent Research From The Laboratory Of And Team At San Antonio
Jun 11, 2016
Equities
VeroScience: VeroScience Continues to Explore Clinical Benefits of Circadian Neuroendocrine Resetting Therapy® with Six Papers Presented at 2016 American Diabetes Association Scientific Sessions June 10-14
Jun 11, 2016
Equities
VeroScience: VeroScience is Pleased to Support Independent Research from the Laboratory of Dr. DeFronzo and Team at UT Health Science Center, San Antonio
Mar 16, 2016
PR Newswire
Press Release: VeroScience : Published Review Paper from VeroScience Delineates 50 Years of Research Linking Circadian Rhythms with Metabolic Disease
Jun 15, 2015
BIOSPACE
VeroScience: VeroScience Release: Two Peer-Reviewed Studies Focusing On Unique Therapeutic Impact Of Veroscience's Cycloset Recently Published In
Jun 08, 2015
BIOSPACE
VeroScience: VeroScience Continues Clinical Evaluation of Bromocriptine-QR (Cycloset) And Neurophysiological Investigations Of Brain Dopamine Regulation Of Metabolism With Eight Papers Presented At The 2015 American Diabetes Association Conference
Jun 06, 2015
PR NEWSWIRE
Press Release: VeroScience : VeroScience Continues Clinical Evaluation of Bromocriptine-QR (Cycloset) and Neurophysiological Investigations of Brain Dopamine Regulation of Metabolism with Eight Papers Presented at the 2015 American Diabetes Association Conference
Jun 06, 2015
BIOPORTFOLIO
VeroScience: VeroScience Continues Clinical Evaluation of BromocriptineQR Cycloset and Neurophysiological Investigations of Brain Dopamine Regulation of Metabolism with Eight Papers Presented at the 2015 American Diabetes Association Conference
VeroScience Competitors
1
2
3
4
5
6
7
8
9
10